Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $28.69 Consensus Target Price from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $28.6923.

A number of research firms recently issued reports on ACHC. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday. UBS Group boosted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Barclays increased their price objective on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 30th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Finally, Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a research report on Monday, May 4th.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $27.35 on Friday. The business’s fifty day moving average price is $28.00 and its 200 day moving average price is $23.59. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.52 billion, a P/E ratio of -2.20, a PEG ratio of 10.90 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 5.95% and a negative net margin of 33.44%.The firm’s revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, research analysts anticipate that Acadia Healthcare will post 1.5 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the period. Federated Hermes Inc. grew its position in Acadia Healthcare by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after acquiring an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after purchasing an additional 696 shares during the period. Public Employees Retirement System of Ohio raised its stake in shares of Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after purchasing an additional 867 shares during the period. Finally, Treasurer of the State of North Carolina lifted its position in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after purchasing an additional 867 shares in the last quarter.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Second-quarter revenue of $865.8 million exceeded expectations of approximately $844.2 million, while adjusted EPS of $0.38 topped consensus estimates. Higher admissions and growth in residential treatment supported operating activity. Acadia Healthcare Q2 Earnings Beat Estimates on Higher Admissions
• Positive Sentiment: Acadia raised or reaffirmed its 2026 outlook, calling for revenue of roughly $3.4 billion to $3.45 billion and adjusted EPS of $1.45 to $1.60. UBS analyst A.J. Rice reiterated a Buy rating and a $39 price target. Acadia Healthcare UBS Rating
• Neutral Sentiment: Institutional ownership was mixed in the latest quarter: Morgan Stanley significantly increased its position, while Wellington Management, Goldman Sachs and other funds reduced holdings. Recent analyst targets have generally clustered near $30, with a median target of $30.
• Negative Sentiment: Net income fell to $10.9 million from $30.1 million a year earlier, and adjusted EPS declined from $0.83 to $0.38. Adjusted EBITDA dropped to $149.2 million from $201.8 million, overshadowing the earnings beat. Acadia Healthcare Slides as Reserve Charge and Weak Profit Trends Overshadow Q2 Beat
• Negative Sentiment: A $28.6 million adjustment to professional and general liability reserves, along with rising liability expenses, pressured margins and raised concerns about reserve risk. Same-facility revenue was flat, indicating that modest patient-day growth did not translate into stronger pricing or favorable revenue mix.
• Negative Sentiment: A securities class-action lawsuit against Acadia was allowed to proceed after a court denied the company’s motion to dismiss, adding a legal overhang for investors. Acadia Healthcare Securities Lawsuit

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.